Nine financial analysts have recently provided ratings on Stryker (NYSE:SYK), with a mix of bullish and somewhat bullish perspectives dominating. The average 12-month price target for SYK has been raised to $361.11, indicating a 6.52% increase from the previous target of $339.00. Analysts from firms including Citigroup, RBC Capital, Truist Securities, Roth MKM, Canaccord Genuity, and Wells Fargo have adjusted their ratings and price targets, reflecting a positive outlook on Stryker's performance. Stryker's financial indicators such as market capitalization, revenue growth, net margin, ROE, and ROA are strong, although its debt-to-equity ratio suggests potential financial challenges.